3D-Printed Orthotics for Plantar Fasciitis
Trial Summary
What is the purpose of this trial?
This trial tests a new method using 3D printing to make custom foot inserts for people with plantar fasciitis. It aims to see if these inserts work better than traditional ones and if patients are satisfied with them. 3D printed foot orthoses have been shown to be effective in treating various foot conditions, including plantar fasciitis, by improving foot biomechanics and comfort.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of 3D-Printed Orthotics for Plantar Fasciitis treatment?
Is it safe to use 3D-printed orthotics for plantar fasciitis?
How does the 3D-printed orthotics treatment for plantar fasciitis differ from other treatments?
The 3D-printed orthotics for plantar fasciitis are unique because they are customized to fit each individual's foot, improving comfort and pressure distribution compared to traditional prefabricated orthotics. This personalized approach can lead to better pain relief and foot function by specifically addressing the biomechanics of the plantar foot.13678
Eligibility Criteria
This trial is for adults over 18 with plantar fasciitis who can communicate electronically. It's not suitable for non-English speakers, Medicare patients, pregnant women, those needing lower leg bracing, or individuals with a history of orthotic use or certain foot conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either traditionally fabricated orthotics or HP Arize 3D-printed orthotics for treatment of plantar fasciitis
Follow-up
Participants are monitored for compliance, satisfaction, and secondary site pain after initiation of orthotic wearing
Treatment Details
Interventions
- HP Arize 3D-Printed Orthotics
- Traditional Orthotics
Find a Clinic Near You
Who Is Running the Clinical Trial?
Prisma Health-Midlands
Lead Sponsor
Hewlett-Packard (HP)
Collaborator